This website, including the information available on this website (“Website”), is for informational purposes only and is not intended as, and should not be interpreted as, medical advice or other professional advice. No healthcare provider–patient relationship is created between you and GeriMedRisk through use of this Website. Never disregard professional medical advice or delay in seeking it because of something you have read, heard, or viewed on this Website. The Website is protected by copyright law and is owned by GeriMedRisk or its licensors. Your use of the Website is at your own risk and liability. You may print or download pages of the Website for your personal, legal, non-commercial use provided that you do not modify any of the content or remove or alter any disclaimers or notices. Clinical judgement is still required. GeriMedRisk does not endorse the use of any of these therapies for COVID, but offers this information in the hopes of decreasing the risk of harmful drug-drug interactions or adverse drug events. We will do our best to update this information.
(Updated January 26, 2022)
The Ontario COVID-19 Science Advisory Table has created a summary that provides an excellent overview of the potential adverse effects and drug-drug interactions (Fluvoxamine - What Prescribers and Pharmacists Need to Know 2 (covid19-sciencetable.ca), and we suggest consulting this document for general information about the drug. Another excellent accessible resource for identifying drug-drug interactions is the Indiana University Drug Interaction Flockhart Table (https://drug-interactions.medicine.iu.edu/MainTable.aspx).
© Copyright 2022 GeriMedRisk. All Rights Reserved.